QA Associate Director & Qualified Person

At Genmab, we are dedicated to building extra[not]ordinary® futures, together, by developing antibody products and groundbreaking, knock-your-socks-off KYSO antibody medicines® that change lives and the future of cancer treatment and serious diseases. We strive to create, champion and maintain a global workplace where individuals’ unique contributions are valued and drive innovative solutions to meet the needs of our patients, care partners, families and employees.

Our people are compassionate, candid, and purposeful, and our business is innovative and rooted in science. We believe that being proudly authentic and determined to be our best is essential to fulfilling our purpose. Yes, our work is incredibly serious and impactful, but we have big ambitions, bring a ton of care to pursuing them, and have a lot of fun while doing so.

Does this inspire you and feel like a fit? Then we would love to have you join us!

The Role

Genmab is seeking an experienced QA Associate Director & Qualified Person for Chemical Intermediates (CI), Biological Intermediates (BI), and Drug Substance (DS). You will direct Quality Assurance oversight of CI, BI, and DS activities supporting commercial products, all manufactured through external partners. In addition, the role contains Qualified Person (QP) responsibilities in accordance with applicable GMP legislation.

This role plays a critical part in safeguarding product quality, patient safety, and supply reliability in a fully outsourced manufacturing model. You will be an important part of the global GMP QA organization to ensure compliance with industry standards and regulations.

The position will be located in Denmark reporting to the Director of QA GMP, Commercial Drug Substance & Intermediate.

Key Responsibilities

The responsibilities will include, but not be limited to:

• Provide end-to-end QA oversight of commercial CI, BI, and DS manufacturing activities at CMOs, ensuring sustained GMP compliance and supply continuity.
• Ensure batch certification and release within delegated authority in accordance with applicable GMP legislation.
• Ensure batches meet approved Marketing Authorisation (MA) requirements prior to certification.
• Maintain independent, documented, and risk-based decision-making for batch disposition.
• Support regulatory inspections as QP representative when applicable.
• Ensure robust review and approval of batch documentation and manufacturing data supporting release decisions, in accordance with Genmab’s Pharmaceutical Quality System.
• Establish and maintain robust quality agreements and governance models with CMOs, ensuring clear accountability and escalation pathways.
• Oversee deviations, CAPAs, change controls, and risk assessments related to commercial CI, BI, and DS manufacturing.
• Ensure QA oversight of continued process verification, ongoing validation, and lifecycle management for commercial processes.
• Drive inspection readiness and lead QA support for regulatory inspections at CMOs, including routine and for-cause inspections.
• Plan, perform, and follow up on audits of CMOs and critical suppliers supporting commercial manufacturing.
• Provide QA input to regulatory submissions, variations, and post-approval changes related to CI, BI, and DS.
• Act as a key QA interface to Supply Chain, proactively identifying and mitigating quality-related risks to commercial supply.
• Contribute to continuous improvement of Genmab’s Pharmaceutical Quality System with focus on commercial operations and outsourced manufacturing.

What We Are Looking For

• You hold a MSc degree or equivalent in life science.
• Minimum 10 years of experience within the pharmaceutical industry, with extensive GMP QA experience supporting commercial CI, BI, and/or Drug Substance manufacturing at CMOs.
• Strong understanding of biologics manufacturing (e.g. monoclonal antibodies) and associated intermediates; experience with chemical intermediates is an advantage.
• Demonstrated experience with commercial-stage CMO oversight, quality agreements, audits, and regulatory inspections.
• Solid knowledge of global GMP and ICH requirements and post-approval lifecycle management.
• Comfortable operating in a high-complexity, supply-critical environment.
• Excellent English communication skills and a pragmatic, risk-based QA mindset.

What You’ll Gain

• A QA expert role with direct impact on commercial product quality, patient safety, and supply reliability.
• The opportunity to build and mature a scalable QP setup supporting a growing commercial portfolio.
• A role combining long-term strategic ownership with hands-on engagement in complex, supply-critical manufacturing activities.
• A collaborative, performance-driven culture that values quality, accountability, and continuous improvement.




The proposed gross annual base salary range for this position, in the primary location, based on a full time schedule is:

DKK732.768,00---1.099.152,00

The final salary offer will depend on several factors, including your skills, qualifications, and experience.

In addition to base salary, this position is eligible to additional forms of compensation, such as discretionary bonuses and long-term incentives.

When you join Genmab, you become a part of a culture that supports your physical, financial, social, and emotional well-being. Our benefits include, but are not limited to:

• Pension
• Health insurance and wellness benefits
• Paid time off
• Employee support programs

Further details on compensation and benefits will be provided during the recruitment process.

About Genmab

Genmab is an international biotechnology company with a core purpose to improve the lives of patients through innovative and differentiated antibody therapeutics. For 25 years, its hard-working, innovative and collaborative team has invented next-generation antibody technology platforms and harnessed translational, quantitative and data sciences, resulting in a proprietary pipeline including bispecific T-cell engagers, antibody-drug conjugates, next-generation immune checkpoint modulators and effector function-enhanced antibodies. By 2030, Genmab’s vision is to transform the lives of people with cancer and other serious diseases with Knock-Your-Socks-Off (KYSO®) antibody medicines.

Established in 1999, Genmab is headquartered in Copenhagen, Denmark with international presence across North America, Europe and Asia Pacific. For more information, please visit Genmab.com and follow us on LinkedIn and X.

Genmab is committed to protecting your personal data and privacy. Please see our privacy policy for handling your data in connection with your application on our website Job Applicant Privacy Notice (genmab.com).